BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22991460)

  • 1. Engineering neonatal Fc receptor-mediated recycling and transcytosis in recombinant proteins by short terminal peptide extensions.
    Sockolosky JT; Tiffany MR; Szoka FC
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16095-100. PubMed ID: 22991460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced FcRn-dependent transepithelial delivery of IgG by Fc-engineering and polymerization.
    Foss S; Grevys A; Sand KMK; Bern M; Blundell P; Michaelsen TE; Pleass RJ; Sandlie I; Andersen JT
    J Control Release; 2016 Feb; 223():42-52. PubMed ID: 26718855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a label-free FcRn-mediated transcytosis assay for in vitro characterization of FcRn interactions with therapeutic antibodies and Fc-fusion proteins.
    Chung S; Lin YL; Nguyen V; Kamen L; Zheng K; Vora B; Song A
    J Immunol Methods; 2018 Nov; 462():101-105. PubMed ID: 30030147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody.
    Monnet C; Jorieux S; Souyris N; Zaki O; Jacquet A; Fournier N; Crozet F; de Romeuf C; Bouayadi K; Urbain R; Behrens CK; Mondon P; Fontayne A
    MAbs; 2014; 6(2):422-36. PubMed ID: 24492301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An engineered affibody molecule with pH-dependent binding to FcRn mediates extended circulatory half-life of a fusion protein.
    Seijsing J; Lindborg M; Höidén-Guthenberg I; Bönisch H; Guneriusson E; Frejd FY; Abrahmsén L; Ekblad C; Löfblom J; Uhlén M; Gräslund T
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17110-5. PubMed ID: 25406323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion of a short peptide that binds immunoglobulin G to a recombinant protein substantially increases its plasma half-life in mice.
    Sockolosky JT; Kivimäe S; Szoka FC
    PLoS One; 2014; 9(7):e102566. PubMed ID: 25057984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.
    Suzuki T; Ishii-Watabe A; Tada M; Kobayashi T; Kanayasu-Toyoda T; Kawanishi T; Yamaguchi T
    J Immunol; 2010 Feb; 184(4):1968-76. PubMed ID: 20083659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct demonstration of a neonatal Fc receptor (FcRn)-driven endosomal sorting pathway for cellular recycling of albumin.
    Schmidt EGW; Hvam ML; Antunes F; Cameron J; Viuff D; Andersen B; Kristensen NN; Howard KA
    J Biol Chem; 2017 Aug; 292(32):13312-13322. PubMed ID: 28637874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of FcRn binding to intestinal uptake of IgG in suckling rat pups and human FcRn-transgenic mice.
    Kliwinski C; Cooper PR; Perkinson R; Mabus JR; Tam SH; Wilkinson TM; Giles-Komar J; Scallon B; Powers GD; Hornby PJ
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(3):G262-70. PubMed ID: 23220220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal Fc receptor FcRn is involved in intracellular transport of the Fc fusion protein aflibercept and its transition through retinal endothelial cells.
    Deissler HL; Lang GK; Lang GE
    Exp Eye Res; 2017 Jan; 154():39-46. PubMed ID: 27836572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered soluble monomeric IgG1 CH3 domain: generation, mechanisms of function, and implications for design of biological therapeutics.
    Ying T; Chen W; Feng Y; Wang Y; Gong R; Dimitrov DS
    J Biol Chem; 2013 Aug; 288(35):25154-25164. PubMed ID: 23867459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Glycan Moieties in Neonatal Fc Receptor Determine Steady-state Membrane Distribution and Directional Transport of IgG.
    Kuo TT; de Muinck EJ; Claypool SM; Yoshida M; Nagaishi T; Aveson VG; Lencer WI; Blumberg RS
    J Biol Chem; 2009 Mar; 284(13):8292-300. PubMed ID: 19164298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered antibody domains with significantly increased transcytosis and half-life in macaques mediated by FcRn.
    Ying T; Wang Y; Feng Y; Prabakaran P; Gong R; Wang L; Crowder K; Dimitrov DS
    MAbs; 2015; 7(5):922-30. PubMed ID: 26179052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury.
    Pyzik M; Rath T; Kuo TT; Win S; Baker K; Hubbard JJ; Grenha R; Gandhi A; Krämer TD; Mezo AR; Taylor ZS; McDonnell K; Nienaber V; Andersen JT; Mizoguchi A; Blumberg L; Purohit S; Jones SD; Christianson G; Lencer WI; Sandlie I; Kaplowitz N; Roopenian DC; Blumberg RS
    Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2862-E2871. PubMed ID: 28330995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A targeted RNAi screen identifies factors affecting diverse stages of receptor-mediated transcytosis.
    Nelms B; Dalomba NF; Lencer W
    J Cell Biol; 2017 Feb; 216(2):511-525. PubMed ID: 28069747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray crystal structures of monomeric and dimeric peptide inhibitors in complex with the human neonatal Fc receptor, FcRn.
    Mezo AR; Sridhar V; Badger J; Sakorafas P; Nienaber V
    J Biol Chem; 2010 Sep; 285(36):27694-701. PubMed ID: 20592032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn
    Mester S; Evers M; Meyer S; Nilsen J; Greiff V; Sandlie I; Leusen J; Andersen JT
    MAbs; 2021; 13(1):1893888. PubMed ID: 33691596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short FcRn-Binding Peptides Enable Salvage and Transcytosis of scFv Antibody Fragments.
    Kelly VW; Sirk SJ
    ACS Chem Biol; 2022 Feb; 17(2):404-413. PubMed ID: 35050570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Half-life-extended recombinant coagulation factor IX-albumin fusion protein is recycled via the FcRn-mediated pathway.
    Chia J; Louber J; Glauser I; Taylor S; Bass GT; Dower SK; Gleeson PA; Verhagen AM
    J Biol Chem; 2018 Apr; 293(17):6363-6373. PubMed ID: 29523681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor.
    Tesar DB; Tiangco NE; Bjorkman PJ
    Traffic; 2006 Sep; 7(9):1127-42. PubMed ID: 17004319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.